FDA Clears Caretaker Medical’s Patient Monitor for Continuous Hemodynamic Parameters
Digital health provider Caretaker Medical has received FDA 510(k) clearance for four new continuous hemodynamic parameters.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
American Heart Association: CVD Genetic Testing in Children Needs Individualized Approach
Cardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families.
Cardiovascular
Latest
Verichem Releases Ready-To-Use HDL/LDL Calibration Verification Kit
Verichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.
NGS Detects Bloodstream Infections in Pediatric Cancer Patients before Symptoms Develop
The Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.
Read MoreFDA Clears High-Sensitivity Troponin-I Blood Test from Abbott
The newly cleared diagnostic could help identify heart attacks several hours sooner than standard troponin tests—and help improve diagnoses in women.
Read More
Randox Introduces sPLA2-llA Assay for Clinical Chemistry Analyzers
Measurement of patient sPLA2-llA levels enables clinicians to gain a comprehensive overview of cardiovascular risk factors and can help them tailor treatment accordingly.
Read More
Mass Spec Test Offers More Accurate Assessment of Heart Disease Risk than Standard Cholesterol Tests
An international study shows that LDL cholesterol is unable to predict future cardiovascular events and fails to identify patients at the highest risk.
Read MoreStaying on Target
This companion article discusses American Diabetes Association targets for the blood glucose levels of diabetic patients, as measured with an HbA1c test.
Read More
High-Sensitivity Troponin I Test Helps to Predict Future Cardiac Events
Research found that Abbott’s high-sensitivity Troponin I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors.
Read More
January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
University of Manchester and Owlstone Medical Awarded £250,000 to Advance Asthma Diagnostics
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MoreCanopy Biosciences Licenses Technology for Error-Corrected Sequencing
The license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.
Read MoreNumares and Mayo Clinic Laboratories Collaborate on Nuclear Magnetic Resonance Diagnostics
The new pathways will focus on conditions such as cardiovascular disease, kidney disease, and liver cancer.
Read More
Cardis Partners Develop Photonic-Based Device to Screen for Arterial Stiffness and Cardiovascular Diseases
The prototype is a mobile, low-cost, point-of-care screening device that takes measurements in a fast, reproducible, and reliable way, with minimal patient contact and minimal skills from the operator.
Read More
FDA Clears MenoCheck as an Aid in the Determination of Menopausal Status
The MenoCheck assay was developed to aid physicians in determining the status of women during menopausal transition.
Read More
Collaboration Brings Cardiac Test to Canada
The simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read More
Mayo Clinic Launches Blood Test to Assess Heart Attack Risk
The test measures blood concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular disease processes.
Read More
Panel Identifies Inherited Early Atherosclerosis Diagnosis and Risk
The 84-gene panel is designed to identify patients with a genetic signature for inherited premature coronary or atherosclerotic disease, such as familial hypercholesterolemia, as well as mature onset diabetes of the young.
Read More